Differential use of available genetic tests among primary care physicians in the United States: Results of a national survey

Genetics in Medicine

Volumn 10, Issue 6, 2008, Pages 404-414

  Shields, Alexandra E ^a,b   Burke, Wylie ^c   Levy, Douglas E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Clinical integration; Genetic screening; Genomics; New technologies; Physicians

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL RESEARCH; COLORECTAL CANCER; GENETIC COUNSELING; GENETIC SCREENING; HEALTH SURVEY; HUMAN; HUNTINGTON CHOREA; NORMAL HUMAN; PATIENT CARE; PHYSICIAN; PRIMARY MEDICAL CARE; UNITED STATES; CLINICAL PRACTICE; CLINICAL TRIAL; GENERAL PRACTITIONER; GENETIC PROCEDURES; HEALTH PERSONNEL ATTITUDE; MASS SCREENING; MINORITY GROUP; PATIENT REFERRAL; PRIMARY HEALTH CARE; UTILIZATION REVIEW;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS AS TOPIC; GENETIC COUNSELING; GENETIC SCREENING; GENETIC TECHNIQUES; HUMANS; MASS SCREENING; MINORITY GROUPS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 48849115241     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181770184     Document Type: Article

References (51)

1. Collins FS, Guttmacher AE. Genomics moves into the medical mainstream. J Am Med Assoc 2001;286:2322-2324.
2. Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000;405:857-865.
3. American College of Obstetrics and Gynecology. Prenatal and preconceptual carrier screening for genetic diseases in individuals of eastern European Jewish descent: ACOG Committee Opinion No 298. Washington, DC: American College of Obstetrics and Gynecology, 2004.
4. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 1999;17:2639-2648.
5. GeneTests: medical genetics information resource. University of Washington, Seattle. Available at: http://www.genetests.org. Accessed June 26, 2005.
6. Skinner MA, Moley JA, Dilley WG, Owzar K, et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005;353:1105-1113.
7. Spear BB, Heath-Chiozzi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med 2001;7:201-204.
8. Umar A, Boland C, Terdiman J, Syngal S, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-268. (Pubitemid 38256271)
9. US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005;143:355-361.
10. Danoviz ME, Pereira AC, Mill JG, Krieger JE. Hypertension, obesity and GNB 3 gene variants. Clin Exp Pharmacol Physiol 2006;33:248-252.
11. Horikawa Y, Oda N, Cox NJ, Li X, et al. Genetic variation in the calpain 10 gene (CAPN10) is associated with type 2 diabetes mellitus. Nat Genet 2000;126:163-175.
12. Hotlzman NA. Primary care physicians as providers of frontline genetic services. Fetal Diagn Ther 1993;8(suppl 1):213-219.
13. Lerman C, Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence in men. Am J Med Genet 2003;118B:48-54.
14. Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: The National Academies Press, 2002.
15. Yach D, Hawkes C, Gould L, Hofman K. The global burden of chronic diseases. J Am Med Assoc 2004;291:2616-2622.
16. Burke W, Emery J. Genetics education for primary-care providers. Nat Rev Genet 2002;3:561-566.
17. Shields AE, Blumenthal DB, Weiss KB, Comstock CB, et al. Barriers to translating emerging genetics research on smoking into clinical practice: perspectives of primary care physicians. J Gen Intern Med 2005;20:131-138.
18. Blumenthal D, Causino N, Chang YC, Culpepper L, et al. The duration of ambulatory visits to physicians. J Fam Pract 1999;48:264-271.
19. Rich EC, Burke W, Heaton CJ, Haga S, et al. Revitalizing the family history in primary care. J Gen Intern Med 2004;19:273-280.
20. Fiscella K, Franks P. Does the content of primary care visits differ by the racial composition of physicians' practices? Am J Med 2006;119:348-353.
21. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries 1989-2000. Med Care 2005;43:320-329.
22. Hall MJ, Olopade OI. Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol 2006;24:2197-2203.
23. Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in Medicare managed care. J Am Med Assoc 2002;287:1288-1294.
24. Bach PB, Pham HH, Schrag D, Tate RC, et al. Primary care physicians who treat blacks and whites. N Engl J Med 2004;351:575-584.
25. Armstrong K, Micco E, Carney A, Stopfer J, et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. J Am Med Assoc 2005;293:1729-1736.
26. Hall MJ, Olopade OI. Confronting genetic testing disparities: knowledge is power. J Am Med Assoc 2005;293:1783-1785.
27. National Center for Health Statistics. Chartbook on trends of health of Americans: National Health Interview Survey 2000. Hyattsville, MD: National Center for Health Statistics, 2002.
28. Wideroff L, Vadaparampil ST, Breen N, Croyle RT, et al. Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet 2003;6:147-156.
29. American Medical Association. AMA Masterfile. Synavant, Fairhaven, NJ, 2002.
30. American College of Obstetrics and Gynecology. Genetic screening for hemoglobi-nopathies: ACOG committee opinion. Washington, DC: American College of Obstetrics and Gynecology, 2000.
31. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington disease. J Med Genet 1994;31:555-559.
32. US Preventive Services Task Force. Guide to clinical preventive services. Baltimore, MD: Williams & Wilkins, 1996.
33. U.S. Department of Health and Human Services. Health Insurance Portability and Accountability Act (HIPAA) of 1996. Public Law 104-191. 104th Congress, 1996.
34. Hughes C, Gomez-Caminero A, Benkendork JL, Kerner J, et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997;32:51-62.
35. Hughes C, Lerman C, Lustbader E. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 1996;40:25-35. (Pubitemid 26283488)
36. Lerman C, Caporaso NE, Audrain J, Main D, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999;18:14-20.
37. Peters N, Rose A, Armstrong K. The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomarkers Prev 2004;13:361-365. (Pubitemid 38737459)
38. Gao Q, Tomlinson G, Das S, Cummings S, et al. Prevalence of BRACA1 and BRACA2 mutations among clinic-based African American families with breast cancer. Hum Genet 2000;107:186-191.
39. Olopade OI, Fackenthal JD, Tainsky MA, Collins F, et al. Breast cancer genetics in African Americans. Cancer 2003;97(suppl 1):236-245.
40. Folstein SE, Chase GA, Wahl WE, McDonnell AM, et al. Huntington disease in Maryland: clinical aspects of racial variation. Am J Hum Genet 1987;41:168-179.
41. Reed TW, Chandler JH, Hughes EH, Davidson RT. Huntington's chorea in Michigan. I. Demography and genetics. Am J Hum Genet 1958;10:210-225.
42. Wright HM, Still CN, Ramson RK. Huntington disease in black kindreds in South Carolina. Arch Neurol 1981;38:412-414.
43. Fronstin P. Sources of health insurance and characteristics of the uninsured: analysis of the March 2006 current population survey. Issue brief no. 298. Washington: Employee Benefit Research Institute, 2006.
44. Blumenthal D, DesRoches C, Donelan K, Ferris T, et al. Health information technology in the United States: the information base for progress. Princeton: Robert Woods Johnson Foundation, 2006.
45. Bosco LA, Gerstman BB, Tomita DK. Variations in the use of medication for the treatment of childhood asthma in the Michigan Medicaid population, 1980-1986. Chest 1993;104:1727-1733.
46. Skaggs DL, Clemens S, Vitale MG, Femino JD, et al. Access to orthopaedic care for children with government versus private insurance in California. Pediatrics 2001; 107:1405-1408.
47. Smith V, Ramesh R, Gifford K, Ellis E, et al. The continuing Medicaid budget challenge: state Medicaid spending growth and cost containment in fiscal years 2004 and 2005. The Henry J Kaiser Family Foundation, 2004.
48. Freedman AN, Wideroff L, Olson L, Davis W, et al. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet 2003;120A:63-71. (Pubitemid 37063834)
49. Carey TS, Garrett J. Patterns of ordering diagnostic tests for patients with acute low back pain. The North Carolina Back Pain Project. Ann Intern Med 1996;125:807-814.
50. Mandelblatt JS, Berg CD, Meropol NJ, Edge SB, et al. Measuring and predicting surgeons' practice styles for breast cancer treatment in older women. Med Care 2001;39:228-242.
51. Peabody JW, Luck J, Glassman P, Dresselhaus TR, et al. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. J Am Med Assoc 2000;283:1715-1722. (Pubitemid 30196212)